Niki BioSolutions, Inc. Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable
Niki BioSolutions, Inc. (NIKI) reported Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable of $1.73 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable · last filed 2023-04-28
| Period end | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable 12 month |
|---|---|
| 2022-12-31 | $1.73M 20-F · filed 2023-04-28 |
| 2021-12-31 | $2.07M 20-F · filed 2023-04-28 |
| 2020-12-31 | $2.15M 20-F · filed 2023-04-28 |
| 2019-12-31 | $1.43M 20-F/A · filed 2023-01-17 |